These conventional (age and dyslipidemia) and non-conventional (increased inflammatory markers and leptin) risk factors promote cardiovascular (CV) diseases in the general population as well as in hypopituitary patients like those with SS (15–19). This evidence concerns the gene LEP and metabolic syndrome.